RxSight, Inc. announced the commercial launch of its newest Light Adjustable Lens, the LAL+. The company now offers two lenses in the Light Adjustable Lens platform: the LAL®? and the Light Adjustable Lens+??

(LAL+). The LAL+ has a modified aspheric anterior surface that creates a small continuous increase in central lens power, which is designed to slightly extend the depth of focus. In addition, RxSight's Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens®?

(LAL/LAL+), RxSight Light Delivery Device (LDD??) and accessories, will be the subject of various doctor presentations at the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Boston on April 5-8, 2024.